| 000 | 01892 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517044232.0 | ||
| 264 | 0 | _c20160818 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1873-2496 | ||
| 024 | 7 |
_a10.1016/j.urolonc.2015.06.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan den Bos, Willemien | |
| 245 | 0 | 0 |
_aSalvage ablative therapy in prostate cancer: international multidisciplinary consensus on trial design. _h[electronic resource] |
| 260 |
_bUrologic oncology _cNov 2015 |
||
| 300 |
_a495.e1-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAblation Techniques _xmethods |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstandards |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Agencies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdiagnosis |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xpathology |
| 650 | 0 | 4 |
_aRadiotherapy _xadverse effects |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aSalvage Therapy |
| 700 | 1 | _aMuller, Berrend G | |
| 700 | 1 | _ade Bruin, Daniel M | |
| 700 | 1 | _ade Castro Abreu, Andre Luis | |
| 700 | 1 | _aChaussy, Christian | |
| 700 | 1 | _aColeman, Jonathan A | |
| 700 | 1 | _aFinelli, Antonio | |
| 700 | 1 | _aGill, Inderbir S | |
| 700 | 1 | _aGross, Mitchell E | |
| 700 | 1 | _aJenniskens, Sjoerd F M | |
| 700 | 1 | _aKahmann, Frank | |
| 700 | 1 | _aLaguna-Pes, M Pilar | |
| 700 | 1 | _aRastinehad, Ardeshir R | |
| 700 | 1 | _aSimmons, Lucy A | |
| 700 | 1 | _aSulser, Tullio | |
| 700 | 1 | _aVillers, Arnauld | |
| 700 | 1 | _aWard, John F | |
| 700 | 1 | _ade la Rosette, Jean J M C H | |
| 773 | 0 |
_tUrologic oncology _gvol. 33 _gno. 11 _gp. 495.e1-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2015.06.015 _zAvailable from publisher's website |
| 999 |
_c25128632 _d25128632 |
||